Endothelial cells in the bone marrow of patients with multiple myeloma

Angelo Vacca, Roberto Ria, Fabrizio Semeraro, Francesca Merchionne, Mauro Coluccia, Angela Boccarelli, Claudio Scavelli, Beatrice Nico, Angela Gernone, Feliciana Battelli, Antonio Tabilio, Diego Guidolin, Maria Teresa Petrucci, Domenico Ribatti, Franco Dammacco

Research output: Contribution to journalArticlepeer-review

Abstract

Endothelial cells (EC) were extracted through a lectin-based method from bone marrow of 57 patients with active multiple myeloma (MM) and compared with their healthy quiescent counterpart, human umbilical vein EC (HUVEC). MMECs exhibit specific antigens that indicate ongoing angiogenesis and embryo vasculogenesis; solid intercellular connections, hence stability of MM neovessels; and frequent interactions with plasma cells, hence tumor dissemination. They show heterogeneous antigen expression, hence existence of subsets. Their main genetic markers are indicative of a vascular phase. They show intrinsic angiogenic ability, because they rapidly form a capillary network in vitro, and extrinsic ability, because they generate numerous new vessels in vivo. They vividly secrete growth and invasive factors for plasma cells. They signal through kinases mandatory for development of neovascularization. Ultrastructurally, they are abnormal and show metabolic activation, like tumor ECs. Thalidomide heavily interferes with their functions. Vasculogenesis and angiogenesis might contribute to the MM vascular tree and progression, in the form of growth, invasion, and dissemination. In view of the heterogeneity of the antigenic phenotype of MMECs, a mixture (or a sequence) of antiangiogenic agents coupled with thalidomide would seem plausible for the biologic management of MM.

Original languageEnglish
Pages (from-to)3340-3348
Number of pages9
JournalBlood
Volume102
Issue number9
DOIs
Publication statusPublished - Nov 1 2003

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Endothelial cells in the bone marrow of patients with multiple myeloma'. Together they form a unique fingerprint.

Cite this